Arvinas ARVN
NASDAQ ARVN
$7.41 -0.02 (-0.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arvinas (ARVN) Non-Current Deffered Revenue (2017 - 2026)

Updated

Arvinas (ARVN) recorded Non-Current Deffered Revenue of $138.2 million in Q1 2026, up 16.7% from $118.4 million a year earlier and up 2.9% from the prior quarter.

Analysis

Arvinas (ARVN) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends

At the end of FY2025, Arvinas reported Non-Current Deffered Revenue of $134.3 million, down 54.0% from FY2024.

  • Annual Non-Current Deffered Revenue has declined for four straight years, though with a five-year compound annual growth rate of 42.4% (FY2020 to FY2025).
  • Across earlier years, Non-Current Deffered Revenue came in at $292 million in FY2024 (-24.4%), $386.2 million in FY2023 (-4.7%), $405.1 million in FY2022 (-24.2%) and $534.3 million in FY2021.
  • The Q1 2026 figure is the highest quarterly Non-Current Deffered Revenue since Q4 2024.
  • On a year-over-year basis, Non-Current Deffered Revenue rose in three of the last eight quarters, with an average decline of 29.0%.
  • Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 16.7% in Q1 2026, against a decline of 67.2% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $134.3 million (Q4 2025), $127.4 million (Q3 2025) and $134.1 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Arvinas 485.18 Mn -2.17 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 138.20 Mn
Dec 31, 2025 134.30 Mn
Sep 30, 2025 127.40 Mn
Jun 30, 2025 134.10 Mn
Mar 31, 2025 118.40 Mn
Dec 31, 2024 292.00 Mn
Sep 30, 2024 304.50 Mn
Jun 30, 2024 331.30 Mn
Mar 31, 2024 361.00 Mn
Dec 31, 2023 386.20 Mn
Sep 30, 2023 281.90 Mn
Jun 30, 2023 310.50 Mn
Mar 31, 2023 378.90 Mn
Dec 31, 2022 405.10 Mn
Sep 30, 2022 464.60 Mn
Jun 30, 2022 493.60 Mn
Mar 31, 2022 521.90 Mn
Dec 31, 2021 534.30 Mn
Sep 30, 2021 600.43 Mn
Jun 30, 2021 14.86 Mn
API Access

Arvinas Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ARVN&period=max&api_key=YOUR_API_KEY